-
Subject Areas on Research
-
3-Halo-5,7-dimethylpyrazolo [1,5-a]pyrimidines, a nonbenzodiazepinoid class of antianxiety agents devoid of potentiation of central nervous system depressant effects of ethanol or barbiturates.
-
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder.
-
A case of infant delirium in the neonatal intensive care unit.
-
A combined treatment approach to anxiety in the medically ill.
-
A comparison of the efficacy of stimulus control for medicated and nonmedicated insomniacs.
-
A prescription for unemployment? Recessions and the demand for mental health drugs.
-
A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth.
-
A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD).
-
Acute tolerance and reversal of the motor control effects of midazolam.
-
Adinazolam sustained-release treatment of panic disorder: a double-blind study.
-
Age-related differences in neurosteroid potentiation of muscimol-stimulated 36Cl(-) flux following chronic ethanol treatment.
-
Alprazolam for endogenous depression.
-
Alprazolam reduces stress hyperglycemia in ob/ob mice.
-
An anxiety-like phenotype in mice selectively bred for aggression.
-
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
-
Anxiety in medically ill older patients: a review and update.
-
Anxiolytic effects of acute morphine can be modulated by nitric oxide systems.
-
Anxiolytic effects of nicotine in zebrafish.
-
Attention bias toward threat in pediatric anxiety disorders.
-
Benzodiazepine and beta-adrenergic receptor ligands independently stimulate phospholipid methylation.
-
Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.
-
Benzodiazepine use and cognitive function among community-dwelling elderly.
-
Benzodiazepines in the intensive care unit.
-
Biological therapies for posttraumatic stress disorder: an overview.
-
Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety.
-
Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
-
Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies.
-
Contemporary management of comorbid anxiety and depression in geriatric patients.
-
Defining an appropriate management strategy for social anxiety disorder.
-
Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders?
-
Effect of a single dose of diazepam on balance measures in older people.
-
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
-
Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
-
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.
-
Emergent anxiety after antidepressant initiation: a retrospective cohort study of Veterans Affairs Health System patients with depression.
-
Endotracheal administration of flumazenil.
-
Endotracheal flumazenil: a new route of administration for benzodiazepine antagonism.
-
Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.
-
Evaluation of temazepam and diphenhydramine as hypnotics in a nursing-home population.
-
Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow.
-
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.
-
Exceptionally high seizure threshold: ECT device limitations.
-
Explanatory attributions of anxiety and recovery in a study of kava.
-
Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil.
-
First-line pharmacotherapy approaches for generalized anxiety disorder.
-
Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
-
Generalized anxiety disorder. An important clinical concern.
-
Generalized anxiety disorder: acute and chronic treatment.
-
Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives.
-
Impact of hospital type II violent events: use of psychotropic drugs and mental health services.
-
Impact of symptoms of generalized anxiety disorder on the course of late-life depression.
-
Inpatient and outpatient patterns of psychotropic drug prescribing by nonpsychiatrist physicians.
-
Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
-
Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.
-
Management of dyspnea within a rapid learning healthcare model.
-
Medial septal benzodiazepine receptors modulate hippocampal evoked responses and long-term potentiation.
-
Midazolam--an anti-emetic?
-
Mitochondrial benzodiazepine receptors regulate steroid biosynthesis.
-
Naturalistic follow-up of youths treated for pediatric anxiety disorders.
-
Neighborhood health center patients who use minor tranquilizers.
-
Neuropeptides modulate compound postsynaptic potentials in basolateral amygdala.
-
North Carolina Medicaid recipient management lock-in program: the pharmacist's perspective.
-
Panic disorder and social phobia: current treatments and new strategies.
-
Paradoxical reactions in children associated with midazolam use during endoscopy.
-
Paroxetine in the treatment of generalised anxiety disorder.
-
Perceived stress in anxiety disorders and the general population: a study of the Sheehan stress vulnerability scale.
-
Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers.
-
Pharmacokinetics and clinical effects of sublingual triazolam in pediatric dental patients.
-
Pharmacotherapy of generalized anxiety disorder.
-
Physician office visits of adults for anxiety disorders in the United States, 1985-1998.
-
Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study.
-
Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.
-
Psychopharmacologic treatment of children and adolescents with anxiety disorders.
-
Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders.
-
Psychotropic drugs on general medical and surgical wards of a teaching hospital.
-
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings.
-
Reducing long-term diazepam prescribing in office practice. A controlled trial of educational visits.
-
Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.
-
Relaxation to assist sleep medication withdrawal.
-
Role of stress in the etiology and treatment of diabetes mellitus.
-
SMARTer discontinuation trial designs for developing an adaptive treatment strategy.
-
Sedation of children for emergency imaging.
-
Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison.
-
Social anxiety disorder in children and adolescents: epidemiology, diagnosis, and treatment.
-
Social anxiety disorder under scrutiny.
-
Social phobia: biological aspects and pharmacotherapy.
-
Spousal depression, anxiety, and suicide after myocardial infarction.
-
Suicide risk analysis among patients assigned to psychotropics and placebo.
-
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.
-
The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
-
The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient.
-
Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety.
-
Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
-
Trajectories of change in youth anxiety during cognitive-behavior therapy.
-
Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications.
-
Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review.
-
Treatment of social phobia with gabapentin: a placebo-controlled study.
-
Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.
-
[Benzodiazepines consumption and risk of dependence in institutionalized geriatric patients].
-
[Endogenous inhibitors of specific benzodiazepine binding in the cerebral cortex of the bull].
-
[Endogenous inhibitors of the specific binding of benzodiazepines in the cerebral cortex].
-
[Molecular mechanisms of the pharmacologic action of benzodiazepines].
-
κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites.